Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· Matt KaeberleinAudio language not provided

Rapamycin for Dogs: The Future of Aging Science? #shorts

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original textText language: English

The future headline: 'Rapamycin increases lifespan in dogs.' While cautiously optimistic, a properly designed clinical trial is key to detecting results. The Dog Aging Project paved the way for companies like Loyal to pursue FDA approval for drugs that may slow aging. See the full interview with Dr. Kaeberlein on the Healthspan Collective: https://www.youtube.com/watch?v=SpP8m98b0W4 #DogAgingProject #Rapamycin #LongevityScience #AnimalHealth #ClinicalTrials

Matt Kaeberlein · 2 min · Source published: 2026-07-18

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…